Name | Number of supported studies | Average coverage | |
---|---|---|---|
epithelial cell | 4 studies | 24% ± 8% |
Insufficient scRNA-seq data for expression of RHNO1 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
intestine | 100% | 744.17 | 966 / 966 | 100% | 37.11 | 527 / 527 |
ovary | 100% | 844.44 | 180 / 180 | 100% | 52.24 | 430 / 430 |
prostate | 100% | 1050.23 | 245 / 245 | 100% | 35.04 | 502 / 502 |
stomach | 100% | 553.95 | 359 / 359 | 100% | 34.79 | 286 / 286 |
brain | 100% | 809.30 | 2639 / 2642 | 100% | 40.15 | 705 / 705 |
esophagus | 100% | 795.03 | 1443 / 1445 | 100% | 39.15 | 183 / 183 |
bladder | 100% | 750.67 | 21 / 21 | 100% | 45.61 | 503 / 504 |
breast | 100% | 654.66 | 459 / 459 | 100% | 48.88 | 1115 / 1118 |
thymus | 100% | 881.89 | 653 / 653 | 100% | 46.39 | 603 / 605 |
skin | 100% | 1287.06 | 1809 / 1809 | 100% | 39.97 | 470 / 472 |
uterus | 99% | 752.68 | 169 / 170 | 100% | 54.67 | 459 / 459 |
kidney | 100% | 727.20 | 89 / 89 | 99% | 27.17 | 893 / 901 |
lung | 99% | 588.03 | 571 / 578 | 100% | 49.91 | 1155 / 1155 |
pancreas | 100% | 422.12 | 327 / 328 | 99% | 31.97 | 176 / 178 |
adrenal gland | 100% | 736.12 | 258 / 258 | 98% | 28.04 | 225 / 230 |
liver | 63% | 162.49 | 143 / 226 | 76% | 13.89 | 307 / 406 |
lymph node | 0% | 0 | 0 / 0 | 100% | 45.22 | 29 / 29 |
spleen | 100% | 910.42 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 56.07 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 35.35 | 1 / 1 |
adipose | 100% | 492.00 | 1200 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 606.65 | 1330 / 1335 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 96% | 19.57 | 77 / 80 |
muscle | 93% | 339.08 | 745 / 803 | 0% | 0 | 0 / 0 |
heart | 86% | 317.10 | 742 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 85% | 793.16 | 790 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0006325 | Biological process | chromatin organization |
GO_1990166 | Biological process | protein localization to site of double-strand break |
GO_0000725 | Biological process | recombinational repair |
GO_0097681 | Biological process | double-strand break repair via alternative nonhomologous end joining |
GO_0071479 | Biological process | cellular response to ionizing radiation |
GO_0034644 | Biological process | cellular response to UV |
GO_0000077 | Biological process | DNA damage checkpoint signaling |
GO_0070318 | Biological process | positive regulation of G0 to G1 transition |
GO_0005694 | Cellular component | chromosome |
GO_0005654 | Cellular component | nucleoplasm |
GO_0000785 | Cellular component | chromatin |
GO_0035861 | Cellular component | site of double-strand break |
GO_0005634 | Cellular component | nucleus |
GO_0140463 | Molecular function | chromatin-protein adaptor activity |
GO_0005515 | Molecular function | protein binding |
Gene name | RHNO1 |
Protein name | RAD9-HUS1-RAD1 interacting nuclear orphan 1 RAD9, HUS1, RAD1-interacting nuclear orphan protein 1 (RAD9, RAD1, HUS1-interacting nuclear orphan protein) |
Synonyms | HKMT1188 C12orf32 RHINO |
Description | FUNCTION: Involved in microhomology-mediated end-joining (MMEJ) DNA repair by promoting recruitment of polymerase theta (POLQ) to DNA damage sites during mitosis . MMEJ is an alternative non-homologous end-joining (NHEJ) machinery that takes place during mitosis to repair double-strand breaks in DNA that originate in S-phase . Accumulates in M-phase; following phosphorylation by PLK1, interacts with POLQ, enabling its recruitment to double-strand breaks for subsequent repair . Also involved in the DNA damage response (DDR) signaling in response to genotoxic stresses such as ionizing radiation (IR) during the S phase . Recruited to sites of DNA damage through interaction with the 9-1-1 cell-cycle checkpoint response complex and TOPBP1 in a ATR-dependent manner . Required for the progression of the G1 to S phase transition . Plays a role in the stimulation of CHEK1 phosphorylation . . |
Accessions | ENST00000535978.5 F5H7S2 ENST00000538636.5 ENST00000461997.5 [Q9BSD3-2] ENST00000618250.4 [Q9BSD3-1] Q9BSD3 F5H0U1 ENST00000366285.5 ENST00000489288.7 [Q9BSD3-1] ENST00000538700.2 F5H795 F5H580 |